Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Faes Farma ( (ES:FAE) ).
Faes Farma, S.A. has announced the acquisition of Laboratorios Edol, a leading Portuguese ophthalmology laboratory, for 75 million euros. This strategic move is expected to double Faes Farma’s sales and EBITDA in Portugal, enhance its international market presence, and create synergies with its current R&D team, particularly in the growing field of ophthalmology.
More about Faes Farma
Faes Farma, S.A. is a pharmaceutical company with a strong presence in the Portuguese market, specializing in the development and commercialization of pharmaceutical products. The company has a diverse portfolio that includes ophthalmology products, and it has been operating in the industry for over 80 years.
YTD Price Performance: 2.46%
Average Trading Volume: 15,993
Technical Sentiment Signal: Sell
Current Market Cap: €1.1B
For a thorough assessment of FAE stock, go to TipRanks’ Stock Analysis page.